ELMIRA, N.Y., Feb. 22, 2018 -- Chemung Financial Corporation (Nasdaq:CHMG) announced today that its Board of Directors has approved a quarterly cash dividend of $0.26 per share, payable on April 2, 2018 to common stock shareholders of record as of the close of business on March 19, 2018.
Chemung Financial Corporation is a $1.7 billion financial services holding company headquartered in Elmira, New York and operates 34 retail offices through its principal subsidiary, Chemung Canal Trust Company, a full-service community bank with full trust powers. Established in 1833, Chemung Canal Trust Company is the oldest locally-owned and managed community bank in New York State. Chemung Financial Corporation is also the parent of CFS Group, Inc., a financial services subsidiary offering non-traditional services including mutual funds, annuities, brokerage services, tax preparation services and insurance, and Chemung Risk Management, Inc., a captive insurance company based in the State of Nevada.
Contact:
Michael J. Wayne
Senior Vice President
(607) 737-3762
[email protected]
This press release may be found at www.chemungcanal.com


Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
ADNOC Gas Targets Up to $4B Profit in 2026
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 



